ARCHIVES

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

In Brief: Murphy New ACS President, Robert McKenna Named President Elect Gehan Receives Gottlief Award

November 18, 1983

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994